Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
The Monthly: February 2020
03 Feb 2020
Mining
Gold: Open Letter to LBMA Board of Directors
By
Paul Mylchreest
29 Jan 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Shield Therapeutics Plc
Life Sciences
Good demand for Feraccru in Europe
By
Dr Martin Hall
28 Jan 2020
Non-Standard Finance
Financials
Sunshine after the rain
By
Mark Thomas
17 Jan 2020
Allergy Therapeutics plc
Life Sciences
Sales growth well above market average
By
Dr Martin Hall
16 Jan 2020
Morses Club Plc
Financials
Value-added, customer-driven expansion from core
By
Mark Thomas
15 Jan 2020
City of London Investment Group
Financials
Perky markets support dividend hike
By
Dr Brian Moretta
15 Jan 2020
Urban Logistics REIT Plc
Property
The staff of life
By
Mike Foster
15 Jan 2020
Shield Therapeutics Plc
Life Sciences
Taking on China
14 Jan 2020
Share ownership: for the many, not the few?
13 Jan 2020
The Monthly: January 2020
10 Jan 2020
Prev
1
...
39
40
41
42
43
...
75
Next